Skip to main content

Table 1 Demographics of subjects in the study

From: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis

Demographic N = 20
Age (years)
 Mean (SD) 41.15 (9.29)
 (Range) (24–55)
Gender
 Male 40% (8/20)
 Female 60% (12/20)
Diagnosis
 Relapsing remitting MS 75% (15/20)
 Primary progressive MS 20% (4/20)
 Secondary progressive MS 5% (1/20)
Disease duration (years)
 Mean = 7.7
  < 3 25% (5/20)
  4–6 25% (5/20)
  7–9 30% (6/20)
  10–12 10% (2/20)
  16–18 5% (1/20)
  19–21 5% (1/20)
Ambulation status
 Wheelchair 55% (11/20)
 Walker 20% (4/20)
 Bilateral cane 5% (1/20)
 Unilateral cane 20% (4/20)
 No assistance 45% (9/20)
Origin
 White/Caucasian 65% (13/20)
 African Descent 10% (2/20)
 Middle Eastern 5% (1/20)
 Other (1 each Hispanic, Brazilian, Panamanian, and multiracial: Hispanic/White/Native American) 20% (4/20)